In Vitro Testing of Targeted Agents with Radiotherapy

MISO DESIGNED A LAB-ON-CHIP TAILOR-MADE for radiotherapy and targeted agents testing to study cell death.

We developed an in vitro 3D-spheroid model to discover synergistic effects of anti-cancer drug candidates with radiotherapy. This will allow biotechs to maximize the efficacy and expand the scope of applications of their lead candidates.


Why Testing, in vitro, drug-Radiotherapy Combinations?

Read our last paper on our combination assay